{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001659","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.216344+00:00","generated_at":"2026-06-08T13:24:21.648180+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Agenus Q3 net loss $64.5M; cash falls to $106.3M; BLA for botensilimab planned mid-2024","bullets":["Net loss of $64.5M for Q3 2023, compared to $56.7M in Q3 2022; nine-month loss $208.9M.","Cash, equivalents, and short-term investments $106.3M at Sep 30, down 45% from $193.4M at Dec 31, 2022.","Total revenue Q3 $24.3M, up 7% YoY; driven by non-cash royalty revenue of $20.4M.","BLA submission for botensilimab/BAL in MSS CRC planned mid-2024; milestone payment from BMS partnership expected by end of 2023.","Pursuing non-dilutive financing: selling non-strategic assets and partial milestone/royalty sales, expected to close by H1 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001659","json":"https://secwatch.observer/filing/0001157523-23-001659.json","markdown":"https://secwatch.observer/filing/0001157523-23-001659.md","text":"https://secwatch.observer/filing/0001157523-23-001659.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000115752323001659/0001157523-23-001659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000115752323001659/a53764435.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T13:24:21.648180+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d429308e3def4a82f0b770fa3cf1d5aaf86026a9","claim":"AGENUS INC reported financial results for the third quarter 2023.","evidence_excerpt":"On November 7, 2023, Agenus Inc. announced its financial results for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1098972/000115752323001659/0001157523-23-001659-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}